| Detected | Trial | Change |
|---|---|---|
| 2026-08-06 | NCT06661720 Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab)… |
Trial sites expanded: 415 -> 421 locations |
| 2026-08-06 | NCT02523014 Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients… |
Trial sites expanded: 780 -> 783 locations |
| 2026-08-06 | NCT07321652 Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment… |
Trial sites expanded: 152 -> 182 locations |
| 2026-08-06 | NCT07200830 Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and… |
Trial sites expanded: 102 -> 112 locations |
| 2026-08-06 | NCT07143487 Family Communications After Genetic Testing |
Trial sites expanded: 276 -> 299 locations |
| 2026-08-06 | NCT06632327 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB… |
Trial sites expanded: 382 -> 415 locations |
| 2026-08-06 | NCT06876714 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+… |
Trial sites expanded: 671 -> 684 locations |
| 2026-08-06 | NCT06931340 Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy… |
Trial sites expanded: 195 -> 200 locations |
| 2026-08-06 | NCT07283939 Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned… |
Trial sites expanded: 344 -> 363 locations |
| 2026-08-06 | NCT05812807 Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a… |
Trial sites expanded: 842 -> 846 locations |
| 2026-08-06 | NCT07215910 Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for… |
Trial sites expanded: 82 -> 97 locations |
| 2026-08-06 | NCT07293247 A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With… |
Trial sites expanded: 33 -> 74 locations |
| 2026-08-02 | NCT00899223 Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute… |
overall status: Active, Not Recruiting → Unknown |
| 2026-07-31 | NCT04939090 Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced… |
date change Primary completion moved earlier: 2027-04-01 -> 2026-04-14 |
| 2026-07-31 | NCT04939090 Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced… |
date change Completion moved earlier: 2027-12-31 -> 2026-12-31 |
| 2026-07-24 | NCT01901094 Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With… |
date change Primary completion pushed: 2026-01-01 -> 2031-01-31 |
| 2026-07-24 | NCT01901094 Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With… |
date change Completion pushed: 2026-01-01 -> 2031-01-31 |
| 2026-07-23 | NCT04114981 Single Fraction Stereotactic Radiosurgery Compared With Fractionated Stereotactic… |
date change Primary completion moved earlier: 2026-09-01 -> 2025-12-14 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT05379153 | Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The… | Anatomic Stage 0 Breast Cancer AJCC v8 | Recruiting |
| NCT06992427 | High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral… | Head and Neck Squamous Cell Carcinoma | Recruiting |
| NCT03150693 | Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly… | B Acute Lymphoblastic Leukemia | Recruiting |
| NCT05008848 | Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program | Cigarette Smoking-Related Carcinoma | Recruiting |
| NCT05673148 | Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for… | Metastatic Colorectal Adenocarcinoma | Recruiting |
| NCT05677490 | mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced… | Advanced Esophageal Adenocarcinoma | Recruiting |
| NCT05812807 | Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a… | Anatomic Stage II Breast Cancer AJCC v8 | Recruiting |
| NCT06632327 | Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB… | Resectable Lung Non-Small Cell Carcinoma | Recruiting |
| NCT06661720 | Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab)… | Clear Cell Renal Cell Carcinoma | Recruiting |
| NCT06876714 | ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+… | Anatomic Stage I Breast Cancer AJCC v8 | Recruiting |
| NCT06931340 | Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy… | Castration-Sensitive Prostate Carcinoma | Recruiting |
| NCT07000084 | Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone)… | Recurrent Non-Muscle Invasive Bladder Carcinoma | Recruiting |
| NCT07200830 | Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and… | Metastatic Castration-Resistant Prostate Carcinoma | Recruiting |
| NCT07215910 | Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for… | Astrocytoma, IDH-Mutant, Grade 3 | Recruiting |
| NCT07321652 | Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment… | Chronic Lymphocytic Leukemia | Recruiting |
| NCT05976763 | Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for… | Mantle Cell Lymphoma | Recruiting |
| NCT00430183 | Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With… | Prostate Cancer | Active, Not Recruiting |
| NCT02750826 | Breast Cancer WEight Loss Study (BWEL Study) | Breast Carcinoma | Active, Not Recruiting |
| NCT04711109 | Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1… | BRCA1 Mutation | Active, Not Recruiting |
| NCT04989504 | Testing the Application of Mepitel Film During Radiation Therapy to Reduce Radiation… | Breast Carcinoma | Active, Not Recruiting |
| NCT04379570 | Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast… | Anatomic Stage I Breast Cancer AJCC v8 | Active, Not Recruiting |
| NCT00887146 | Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy… | Brain and Central Nervous System Tumors | Active, Not Recruiting |
| NCT04455750 | A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With… | Castration-Resistant Prostate Carcinoma | Active, Not Recruiting |
| NCT04340141 | Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable… | Pancreatic Adenosquamous Carcinoma | Active, Not Recruiting |
| NCT03414970 | Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients… | Ductal Breast Carcinoma | Active, Not Recruiting |